Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by BioAtla, Inc.

BioAtla to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
From BioAtla, Inc.
Via GlobeNewswire
Tickers BCAB
BioAtla Presented Phase 2 Clinical Trial Data at the IASLC 2023 North America Conference on Lung Cancer and Virtual KOL Event
From BioAtla, Inc.
Via GlobeNewswire
Tickers BCAB
BioAtla to Participate in the JMP Securities Hematology and Oncology Summit
From BioAtla, Inc.
Via GlobeNewswire
Tickers BCAB
BioAtla to Host Virtual KOL Event to Review IASLC Data on BA3011 in NSCLC
From BioAtla, Inc.
Via GlobeNewswire
Tickers BCAB
BioAtla Reports Third Quarter 2023 Financial Results and Highlights Recent Progress
From BioAtla, Inc.
Via GlobeNewswire
Tickers BCAB
BioAtla to Participate in the Jefferies London Healthcare Conference
From BioAtla, Inc.
Via GlobeNewswire
Tickers BCAB
BioAtla’s Jay M. Short, Ph.D., Selected for The Explorers Club Lowell Thomas Award
From BioAtla, Inc.
Via GlobeNewswire
Tickers BCAB
BioAtla Provides Guidance on Near-Term Milestones and Plans to Announce Third Quarter 2023 Financial Results and Business Update on November 7, 2023
From BioAtla, Inc.
Via GlobeNewswire
Tickers BCAB
BioAtla to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
From BioAtla, Inc.
Via GlobeNewswire
Tickers BCAB
BioAtla to Participate in Upcoming Investor Conferences in August
From BioAtla, Inc.
Via GlobeNewswire
Tickers BCAB
BioAtla Reports Second Quarter 2023 Financial Results and Highlights Recent Progress
From BioAtla, Inc.
Via GlobeNewswire
Tickers BCAB
BioAtla to Announce Second Quarter 2023 Financial Results and Provide Business Highlights on August 1, 2023
From BioAtla, Inc.
Via GlobeNewswire
Tickers BCAB
BioAtla Added to Membership of U.S. Small-Cap Russell 2000® Index
From BioAtla, Inc.
Via GlobeNewswire
Tickers BCAB
BioAtla to Participate in the Jefferies Healthcare Conference
From BioAtla, Inc.
Via GlobeNewswire
Tickers BCAB
BioAtla Reports First Quarter 2023 Financial Results and Highlights Recent Progress
From BioAtla, Inc.
Via GlobeNewswire
Tickers BCAB
BioAtla to Participate in the JMP Securities Life Sciences Conference
From BioAtla, Inc.
Via GlobeNewswire
Tickers BCAB
BioAtla to Announce First Quarter 2023 Financial Results and Provide Business Highlights on May 11, 2023
From BioAtla, Inc.
Via GlobeNewswire
Tickers BCAB
BioAtla Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Progress
From BioAtla, Inc.
Via GlobeNewswire
Tickers BCAB
BioAtla to Announce Fourth Quarter and Full-Year 2022 Financial Results and Provide Business Highlights
From BioAtla, Inc.
Via GlobeNewswire
Tickers BCAB
BioAtla Announces Change in Executive Leadership
From BioAtla, Inc.
Via GlobeNewswire
Tickers BCAB VTRS
BioAtla Announces FDA Clearance of Investigational New Drug Application for BA3182, a CAB-EpCAMxCAB-CD3 Bispecific T-Cell Engager for the Treatment of Advanced Adenocarcinoma
From BioAtla, Inc.
Via GlobeNewswire
Tickers BCAB
BioAtla Provides Clinical Program Updates and Upcoming 2023 Milestones
From BioAtla, Inc.
Via GlobeNewswire
Tickers BCAB
BioAtla to Participate in the 41st Annual J.P. Morgan Healthcare Conference
From BioAtla, Inc.
Via GlobeNewswire
Tickers BCAB
BioAtla to Participate in the Jefferies London Healthcare Conference
From BioAtla, Inc.
Via GlobeNewswire
Tickers BCAB
BioAtla Announces $65 Million Underwritten Offering of its Common Stock
From BioAtla, Inc.
Via GlobeNewswire
Tickers BCAB
BioAtla Reports Third Quarter 2022 Financial Results and Highlights Recent Progress
From BioAtla, Inc.
Via GlobeNewswire
Tickers BCAB
BioAtla to Announce Third Quarter 2022 Financial Results and Provide Business Highlights on November 3, 2022
From BioAtla, Inc.
Via GlobeNewswire
Tickers BCAB
BioAtla to Announce Second Quarter 2022 Financial Results and Provide Business Highlights on August 9, 2022
From BioAtla, Inc.
Via GlobeNewswire
Tickers BCAB
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.